Payal Kohli, MD
Cardiovascular Disease · Aurora, CONPI 1447459771
Payments from drug & device makers
Across 1,729 payments — averaging $993.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$333K
- Esperion Therapeutics, Inc.$296K
- Merck$218K
- Amarin Pharma, Inc.$161K
- Bayer$153K
- Lilly USA, LLC$101K
- plus $457K from 21 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 378 | $332,550 |
| Esperion Therapeutics, Inc. | 265 | $295,971 |
| Merck | 207 | $217,603 |
| Amarin Pharma, Inc. | 133 | $160,573 |
| Bayer | 123 | $152,999 |
| Lilly USA, LLC | 128 | $101,292 |
| Novo Nordisk | 63 | $93,623 |
| Boston Scientific | 99 | $87,401 |
| E.r. Squibb & Sons, L.L.C. | 45 | $63,380 |
| Heartflow, Inc. | 39 | $47,539 |
| AstraZeneca | 56 | $46,304 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 74 | $44,516 |
| Boehringer Ingelheim | 22 | $25,905 |
| Novartis | 26 | $25,882 |
| Agepha Pharma FZ LLC | 13 | $15,022 |
| Idorsia Pharmaceuticals US Inc | 2 | $3,179 |
| Abbott | 20 | $1,670 |
| Medtronic(2 entities) | 5 | $1,187 |
| Biotronik Inc. | 11 | $753 |
| Artivion, Inc. | 4 | $526 |
| Philips North America LLC | 5 | $124 |
| Lexicon Pharmaceuticals, Inc. | 2 | $69 |
| Pfizer | 3 | $57 |
| Scpharmaceuticals Inc. | 3 | $45 |
| Sanofi Pasteur Inc. | 1 | $25 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $22 |
| Medicure Pharma Inc. | 1 | $17 |
How this compares
$1,718,232 in reported general payments places this provider in the 95th percentile of 276 cardiovascular disease providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Aurora
- Marc BonacaAurora$1.2M
- William SauerAurora$978K
- Brack HattlerAurora$699K
- John OrdAurora$176K
- Steven SimonAurora$168K
- Rhonda MiyasakaAurora$128K
- Gregory SchwartzAurora$122K
- Edward GillAurora$96K
- Luisa MestroniAurora$80K
- Joseph AdewumiAurora$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.